← Leaderboards
William Reed Henderson
University Of Washington
$4,865,369
Attributed
$4,865,369
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $945.9K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$4,865,369 · 3
By mechanism
R01$4,857,641 · 2
M01$7,728 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Teal S Hallstrand$15,720,308
- Michael H Gelb$24,827,130
- Bruce H Robinson$2,096,299
- Catherine J Karr$19,073,534
- Alan Chait$20,398,633
Others in their field
Top investigators on “Pulmonary Fibrosis /Granuloma”
- Sem H Phan · University Of Michigan At Ann Arbor$4,606,219
- Edward F Haponik · Johns Hopkins University$4,302,488
- Eric P Hoffman · Reveragen Biopharma, Inc.$3,519,267
- David A Schwartz · University Of Iowa$3,135,004
- Alan L Scott · Johns Hopkins University$3,065,927
- Steven Lynn Kunkel · University Of Michigan At Ann Arbor$3,059,171
Research focus
Pulmonary Fibrosis /GranulomaInflammationAsthmaLaboratory MousePlatelet Activating FactorImmunocytochemistryLeukocyte Activation /TransformationProstaglandin Endoperoxide SynthaseT LymphocyteScanning Transmission Electron MicroscopyOvalbuminAllergensLipoxygenaseMolecular PathologyLeukotrienesPharmacokineticsClinical ResearchHuman SubjectEnzyme ActivityHistologyEnzyme InhibitorsIsozymesDiagnostic Respiratory LavageBronchomotion
Grant awards (14)
5-Lipoxygenase Products in Asthmatic Immune Response$324,915
R01 · FY2008 · AI · contact PI
5-Lipoxygenase Products in Asthmatic Immune Response$331,208
R01 · FY2007 · AI · contact PI
Chemogenomics to Identify New Molecular Targets in PF$590,587
R01 · FY2006 · HL · contact PI
5-Lipoxygenase Products in Asthmatic Immune Response$333,085
R01 · FY2006 · AI · contact PI
Chemogenomics to Identify New Molecular Targets in PF$604,800
R01 · FY2005 · HL
5-Lipoxygenase Products in Asthmatic Immune Response$341,100
R01 · FY2005 · AI
Chemogenomics to Identify New Molecular Targets in PF$604,800
R01 · FY2004 · HL
5-Lipoxygenase Products in Asthmatic Immune Response$341,100
R01 · FY2004 · AI
Chemogenomics to Identify New Molecular Targets in PF$617,700
R01 · FY2003 · HL
5-LIPOXYGENASE PRODUCTS IN ASTHMATIC IMMUNE RESPONSE$262,737
R01 · FY2002 · AI
5-LIPOXYGENASE PRODUCTS IN ASTHMATIC IMMUNE RESPONSE$256,415
R01 · FY2001 · AI
5-LIPOXYGENASE PRODUCTS IN ASTHMATIC IMMUNE RESPONSE$249,194
R01 · FY2000 · AI
PHASE 2A STUDY OF RPAF AH IN ALLERGEN CHALLENGE IN MILD ASTHMATICS$3,864
M01 · FY2000 · RR
PHASE 2A STUDY OF RPAF AH IN ALLERGEN CHALLENGE IN MILD ASTHMATICS$3,864
M01 · FY2000 · RR